Quality of life and survival of achieving textbook outcome for resectable esophageal squamous cell carcinoma.

J Thorac Dis · 2025 · PMC12780393 · PMID 41522176

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

Although the OS and DFS benefit for TO patients did reach marginal significance in long-term follow-up (log-rank P=0.06/0.08, the TO group demonstrated a significant survival advantage within 60 months post-surgery, with higher OS (68.8% vs. 59.3%; HR 0.59, P=0.01) and DFS (62.9% vs. 55.6%; HR 0.64, P=0.02) compared to the non-TO group.

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.